+467.0%
MRNA vs ELAN
+25.6%
+441.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ELAN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.4% | +4.0% | +4.4% |
| 7D | -1.1% | -5.4% | +4.3% | +3.2% |
| 30D | +126.1% | +4.7% | +121.4% | +130.7% |
| 3M | +190.0% | -3.7% | +193.7% | +201.6% |
| 6M | +157.2% | -1.2% | +158.4% | +162.2% |
| YTD | +388.2% | +2.4% | +385.8% | +391.9% |
| 1Y | +467.0% | +23.4% | +443.7% | +423.1% |
| All | +467.0% | +25.6% | +441.5% | +423.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ELAN.
Daily Out/Under-Performance
Portfolio return minus ELAN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ELAN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ELAN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling